ACADIA Pharmaceuticals Inc. (LON:0A4W)
London · Delayed Price · Currency is GBP · Price in USD 26.87
+8.25 (44.31%)
At close: Dec 10, 2025
ACADIA Pharmaceuticals Market Cap
ACADIA Pharmaceuticals has a market cap or net worth of 3.42 billion as of December 30, 2025. Its market cap has increased by 51.22% in one year.
Market Cap
3.42B
Enterprise Value
2.83B
Revenue
778.99M
Ranking
n/a
PE Ratio
17.60
Stock Price
26.87
Market Cap Chart
Since May 27, 2004, ACADIA Pharmaceuticals's market cap has increased from 61.44M to 3.42B, an increase of 5,464.86%. That is a compound annual growth rate of 20.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 3.35B | 37.47% |
| Dec 31, 2024 | 2.44B | -39.57% |
| Dec 29, 2023 | 4.04B | 88.62% |
| Dec 30, 2022 | 2.14B | -22.79% |
| Dec 31, 2021 | 2.77B | -55.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 212.05B |
| HSBC Holdings | 201.54B |
| Shell | 154.45B |
| Unilever | 107.12B |
| Rio Tinto Group | 102.20B |
| Rolls-Royce Holdings | 96.22B |
| British American Tobacco p.l.c. | 91.59B |
| GSK plc | 72.45B |